MedPath

ADENOSINE INJECTION

ADENOSINE INJECTION

Approved
DIN Number

02457474

Drug Class

Human

Market Date

Aug 17, 2017

Company
HC

fresenius kabi canada ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02457474
AIG Number0113219001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C01EB10 ADENOSINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification24:04.04.24
Health Canada Classification

ACTIVE INGREDIENTS (1)

ADENOSINEActive
Strength: 3 MG / ML
Monograph: ADENOSINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.